Position in NVO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$522,546
+$101,869 QoQ
Shares Held
10,900
-4.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#701
of 1,348 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Innovative Asset Advisors Group, LLC holds $6,571,813 across 9 Drug Manufacturers - General names. NVO ranks #6 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,351 | $1,358,993 | |
| 2 | ABBV |
AbbVie Inc.
|
4,797 | $1,207,117 | |
| 3 | PFE |
Pfizer Inc
|
46,465 | $1,118,877 | |
| 4 | LLY |
ELI LILLY & Co
|
748 | $897,173 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,088 | $782,308 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
10,900 | $522,546 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,985 | $344,855 | |
| 8 | AMGN |
Amgen Inc
|
656 | $237,550 |
All Filings in NVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $522,546 | 10,900 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $420,677 | 11,447 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||